Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Jurdi NE, Hoover A, O'Leary D, Cao Q, Gupta A, Ebens C, Maakaron JE, Betts BC, Rashidi A, Juckett MB, Lund T, Bachanova V, MacMillan ML, Miller JS, Orchard PJ, Wagner JE, Vercellotti G, Weisdorf DJ, Dusenbery K, Terezakis S, Holtan SG. Jurdi NE, et al. Transplant Cell Ther. 2023 Sep;29(9):576.e1-576.e5. doi: 10.1016/j.jtct.2023.06.008. Epub 2023 Jun 11. Transplant Cell Ther. 2023. PMID: 37311510 Clinical Trial.
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease.
Holtan SG, Hoeschen A, Cao Q, Ustun C, Betts BC, Jurdi NE, Maakaron J, Rashidi A, Miller JS, Wagner JE, Blazar BR, Jacobson PA, Panoskaltsis-Mortari A, Weisdorf DJ, MacMillan ML. Holtan SG, et al. Among authors: jurdi ne. Transplant Cell Ther. 2023 Aug;29(8):509.e1-509.e8. doi: 10.1016/j.jtct.2023.05.021. Epub 2023 Jun 4. Transplant Cell Ther. 2023. PMID: 37279855 Free PMC article. Clinical Trial.
Frailty in Patients with Chronic Graft-versus-Host Disease.
Rashid N, Arora M, Jurdi NE, Onstad L, Pidala JA, Flowers ME, Lee SJ. Rashid N, et al. Among authors: jurdi ne. Transplant Cell Ther. 2023 Jun;29(6):367-374. doi: 10.1016/j.jtct.2023.03.010. Epub 2023 Mar 14. Transplant Cell Ther. 2023. PMID: 36921916
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.
Holtan SG, Savid-Frontera C, Walton K, Eaton AA, Demorest C, Hoeschen A, Zhang L, Reid K, Kurian T, Sayegh Z, Julia E, Maakaron J, Bachanova V, Jurdi NE, MacMillan ML, Weisdorf DJ, Felices M, Miller JS, Blazar BR, Davila ML, Betts BC. Holtan SG, et al. Among authors: jurdi ne. Clin Cancer Res. 2023 Mar 14;29(6):1114-1124. doi: 10.1158/1078-0432.CCR-22-2837. Clin Cancer Res. 2023. PMID: 36622700 Free PMC article.
Do Cancer and Cancer Treatments Accelerate Aging?
Bhatia R, Holtan S, Jurdi NE, Prizment A, Blaes A. Bhatia R, et al. Among authors: jurdi ne. Curr Oncol Rep. 2022 Nov;24(11):1401-1412. doi: 10.1007/s11912-022-01311-2. Epub 2022 Jul 7. Curr Oncol Rep. 2022. PMID: 35796942 Free PMC article. Review.
Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation.
Saqr A, Carlson B, Staley C, Rashidi A, Al-Kofahi M, Kaiser T, Holtan S, MacMillan M, Young JA, Jurdi NE, Weisdorf D, Khoruts A, Jacobson PA. Saqr A, et al. Among authors: jurdi ne. Transplant Cell Ther. 2022 Jul;28(7):372.e1-372.e9. doi: 10.1016/j.jtct.2022.04.018. Epub 2022 Apr 27. Transplant Cell Ther. 2022. PMID: 35489611 Free article.
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Gauntner TD, Brunstein CG, Cao Q, Weisdorf D, Warlick ED, Jurdi NE, Maakaron JE, Arora M, Betts BC, Bachanova V, Holtan SG, He FC. Gauntner TD, et al. Among authors: jurdi ne. Transplant Cell Ther. 2022 Feb;28(2):88-95. doi: 10.1016/j.jtct.2021.11.004. Epub 2021 Nov 10. Transplant Cell Ther. 2022. PMID: 34774817 Free article.
12 results